Advisory Services Network’s Takeda Pharmaceutical TAK Stock Holding History

Advisory Services Network’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$981K	Buy	+52,964	New	+$930K	0.01%	947
2025 Q4	–	Sell	-5,040	Closed	-$73.8K	–	3985
2025 Q3	$73.8K	Buy	+5,040	New	+$74.8K	﹤0.01%	2233
2024 Q1	–	Sell	-5,862	Closed	-$83.7K	–	3423
2023 Q4	$83.7K	Buy	+5,862	New	+$83.2K	﹤0.01%	1742
2023 Q2	–	Sell	-7,205	Closed	-$119K	–	3428
2023 Q1	$119K	Buy	7,205 +45	+0.6%	+$717	﹤0.01%	1559
2022 Q4	$112K	Buy	+7,160	New	+$100K	﹤0.01%	1548
2021 Q3	–	Sell	-1,467	Closed	-$25K	–	3033
2021 Q2	$25K	Buy	+1,467	New	+$25K	﹤0.01%	2401
2021 Q1	–	Sell	-4,550	Closed	-$83K	–	2772
2020 Q4	$83K	Buy	4,550 +470	+12%	+$8.25K	﹤0.01%	1416
2020 Q3	$73K	Buy	+4,080	New	+$74.3K	﹤0.01%	1399
2020 Q2	–	Sell	-2,007	Closed	-$30K	–	2554
2020 Q1	$30K	Sell	2,007 -900	-31%	-$16.3K	﹤0.01%	1640
2019 Q4	$57K	Buy	2,907 +831	+40%	+$15.9K	﹤0.01%	1431
2019 Q3	$37K	Hold	2,076	–	–	﹤0.01%	1522
2019 Q2	$37K	Buy	2,076 +1,046	+102%	+$19K	﹤0.01%	1520
2019 Q1	$21K	Buy	+1,030	New	+$20.7K	﹤0.01%	1604

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisory Services Network's TAK Position: Q1 2026 in Review

Advisory Services Network opened a new position in Takeda Pharmaceutical (TAK) in Q1 2026: 52,964 shares worth $981K. The stake represents 0.01% of the portfolio and ranks #947 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in TAK as recently as Q3 2025.

Advisory Services Network first reported a position in TAK in Q1 2019 and has held it in 13 quarters since. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

Advisory Services Network held 52,964 shares of Takeda Pharmaceutical worth $981K as of Q1 2026.
Takeda Pharmaceutical was a new Advisory Services Network position in Q1 2026.
Takeda Pharmaceutical made up 0.01% of Advisory Services Network's portfolio in Q1 2026, its #947 holding.
Advisory Services Network first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 13 quarters since.
358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.